Table: Rohto -Q1 group results

Rohto Pharmaceutical

09/08/2022 07:00

Aug 9 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               52.26               42.32           225.00    
                   (+23.5 pct)                          (+12.7 pct) 
  Operating            8.30                6.03            30.00    
                   (+37.8 pct)                          (+2.2 pct)  
  Recurring            9.66                6.54            31.00    
                   (+47.7 pct)                          (+6.6 pct)  
  Net                  6.99                4.75            21.50    
                   (+47.3 pct)                          (+2.3 pct)  
  EPS               61.32 yen           41.64 yen       188.48 yen  
  EPS Diluted       61.14 yen           41.52 yen                   
  Ann Div                               36.00 yen        40.00 yen  
  -Q2 div                               15.00 yen        20.00 yen  
  -Q4 div                               21.00 yen        20.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T